BDBM646015 (2S,4R)-4-hydroxy-1-((2R)-2-(3-(2-(2-(2- hydroxyphenyl)-5,6,6a,7,9,10-hexahydro-8H- pyrazino[1',2':4,5]pyrazino[2,3-c]pyridazin-8- yl)ethoxy)isoxazol-5-yl)-3-methylbutanoyl)- N-((S)-1-(4-(4-methyl-1lambda3,3lambda2-thiazol-5- yl)phenyl)ethyl)pyrrolidine-2-carboxamide (Mixture of Diastereomers at *)::US20240018158, Example 4

SMILES Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](c2cc(OCCN3CCN4c5cc(-c6ccccc6O)nnc5NCC4C3)no2)C(C)C)cc1

InChI Key InChIKey=OTLUUZZFLYCKOU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 646015   

TargetProbable global transcription activator SNF2L2(Human)
Prelude Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 646015BDBM646015((2S,4R)-4-hydroxy-1-((2R)-2-(3-(2-(2-(2- hydroxyph...)
Affinity DataIC50: 100nMAssay Description:The inhibitory activity of compounds was evaluated in vitro using TR-FRET assay with white 384-well low volume microplate (PerkinElmer ProxiPlate Plu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
US Patent